R Takayanagi Selected Research

R Takayanagi Research Topics

Disease

3	Type 2 Diabetes Mellitus (MODY) 08/2011 - 05/2000
2	Diabetic Nephropathies (Diabetic Nephropathy) 07/2012 - 08/2007
2	Albuminuria 07/2012 - 08/2007
2	Breast Neoplasms (Breast Cancer) 12/2001 - 08/2000
2	Neoplasms (Cancer) 12/2001 - 07/2001
2	Osteoporosis 11/2001 - 09/2001
2	Addison Disease (Addison's Disease) 06/2000 - 01/2000
1	Asthma (Bronchial Asthma) 09/2014
1	Insulin Resistance 08/2011
1	Glucose Intolerance 08/2011
1	Obesity 06/2011
1	Rheumatoid Arthritis 01/2011
1	Cicatrix (Scar) 01/2011
1	Ulcer 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2010
1	Carcinoma (Carcinomatosis) 01/2010
1	Ulcerative Colitis 01/2008
1	Pancreatitis 10/2006
1	Hyperamylasemia 10/2006
1	Vomiting 11/2001
1	Nausea 11/2001
1	Brain Diseases (Brain Disorder) 09/2000
1	Human Influenza (Influenza) 09/2000
1	Hypothermia 09/2000
1	Pseudohypoaldosteronism 06/2000
1	Hyperplasia 06/2000
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 06/2000
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2000
1	Anemia 05/2000
1	Acute Erythroblastic Leukemia (Erythroleukemia) 05/2000
1	Leukemia 05/2000
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2000

Drug/Important Bio-Agent (IBA)

5	PPAR gammaIBA 12/2001 - 05/2000
4	Troglitazone (Rezulin)FDA Link 12/2001 - 05/2000
4	LigandsIBA 12/2001 - 05/2000
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2001 - 08/2000
3	Aromatase (CYP19)IBA 12/2001 - 08/2000
2	pitavastatin (itavastatin)FDA Link 07/2012 - 08/2007
2	Insulin (Novolin)FDA Link 08/2011 - 05/2000
2	Messenger RNA (mRNA)IBA 08/2007 - 07/2001
2	LG 100268IBA 12/2001 - 08/2000
2	Retinoid X Receptors (Retinoid X Receptor)IBA 12/2001 - 08/2000
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2001 - 08/2000
2	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2001 - 08/2000
2	Cholecalciferol (Vitamin D3)FDA Link 12/2001 - 08/2000
2	Estrogens (Estrogen)FDA Link 12/2001 - 08/2000
2	4- (2- (5,6,7,8- tetrahydro- 5,5,8,8- tetramethyl- 2- naphthalenyl)- 1- propenyl)benzoic acidIBA 12/2001 - 08/2000
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	Receptors for Activated C KinaseIBA 09/2014
1	Pravastatin (Pravachol)FDA LinkGeneric 07/2012
1	CreatinineIBA 07/2012
1	AlbuminsIBA 07/2012
1	Glucose (Dextrose)FDA LinkGeneric 08/2011
1	BilirubinIBA 08/2011
1	Biliverdine (Biliverdin)IBA 08/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2011
1	tocilizumab (atlizumab)FDA Link 01/2011
1	PlatinumIBA 01/2010
1	nedaplatinIBA 01/2010
1	8-Hydroxy-2'-DeoxyguanosineIBA 08/2007
1	Fibronectins (Fibronectin)IBA 08/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2007
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2007
1	Amylases FDA Link 10/2006
1	Antineoplastic Agents (Antineoplastics)IBA 11/2001
1	ramosetron (Nasea)IBA 11/2001
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 11/2001
1	Dehydroepiandrosterone (DHEA)IBA 11/2001
1	Indicators and Reagents (Reagents)IBA 09/2001
1	rho-Associated KinasesIBA 09/2001
1	GlucocorticoidsIBA 09/2001
1	CytochromesIBA 07/2001
1	RNA (Ribonucleic Acid)IBA 07/2001
1	Amantadine (Aman)FDA LinkGeneric 09/2000
1	Methylprednisolone FDA LinkGeneric 09/2000
1	urinastatin (MR 20)IBA 09/2000
1	Hormones (Hormone)IBA 08/2000
1	Hydroxysteroid DehydrogenasesIBA 06/2000
1	Mixed Function Oxygenases (Monooxygenases)IBA 06/2000
1	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 06/2000
1	EnzymesIBA 06/2000
1	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 06/2000
1	ThiazolidinedionesIBA 05/2000
1	2,4-thiazolidinedione (thiazolidinedione)IBA 05/2000
1	Inhibins (Inhibin)IBA 01/2000
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2000

Therapy/Procedure

4	Therapeutics 01/2011 - 09/2000
2	Drug Therapy (Chemotherapy) 01/2010 - 11/2001
1	Radiotherapy 01/2010
1	Intramuscular Injections 01/2000